This may lead to oxidative stress in CML cells, resulting in their damage since BCR/ABL contains redox-sensitive cysteine residues that may be oxidized by ROS, causing changes in its structure and stability as a consequence. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.